You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 10, October 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preoperative Evaluation of Abnormal Mammographic Findings to Avoid Unnecessary Breast Biopsies

Monica Morrow, MD; Robert Schmidt, MD; Betsy Cregger; Cathy Hassett, RN; Susan Cox, RN

Arch Surg. 1994;129(10):1091-1096.


Abstract

Objective
To prospectively evaluate a program of additional mammographic views, interval follow-up, and stereotactic biopsy in the management of abnormalities detected on mammograms.

Methods
From June 1988 to September 1991, 267 consecutive women who were referred for surgical consultation because of an abnormal mammographic finding were evaluated. Mammographic abnormalities were assessed as benign or as requiring interval follow-up, stereotactic biopsy, open surgical biopsy, or additional views. Women having additional mammographic views were reassigned to the preceding groups. The mean follow-up for women who did not have a biopsy was 37 months.

Results
Only 129 (48%) of the women who were sent for surgical consultation underwent open biopsy, and 46 (36%) of the biopsy specimens revealed carcinoma. Forty-one (89%) of the cancers were ductal carcinoma in situ or stage I lesions. Of the 117 women who were assigned to follow-up, six (5%) subsequently required biopsy and two cancers were identified.

Conclusion
Rigorous mammographic evaluation and the use of stereotactic biopsy for selected lesions can prevent breast biopsy for low-suspicion mammographic abnormalities while still allowing the detection of early-stage breast cancer.

(Arch Surg. 1994;129:1091-1096)



Author Affiliations

From the Departments of Surgery (Dr Morrow and Mss Cregger and Hassett) and Radiology (Dr Schmidt and Ms Cox), University of Chicago (Ill). Dr Morrow is now with the Department of Surgery, Northwestern University, Chicago.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Current Management of Patients with Ductal Carcinoma-in-Situ
Chabner et al.
The Oncologist 1997;2:76-82.
ABSTRACT | FULL TEXT  

A 47-Year-Old Woman With Ductal Carcinoma In Situ of the Breast
Kaufman
JAMA 1996;275:1477-1477.
ABSTRACT  

A 47-Year-Old Woman With Ductal Carcinoma In Situ
Morrow
JAMA 1996;275:61-66.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.